Press Release Distribution & News Releases

Industry News

InfoComm India 2024 -The Largest Edition of the Pro AV Exhibition to Date - Returns 3-5 September at Jio World Convention Centre (JWCC) Mumbai, India

MUMBAI, India, July 26, 2024 /PRNewswire/ -- InfoComm India, India's foremost professional audiovisual (Pro AV) exhibition, is set to return toMumbai from 3-5 September 2024 at the Jio World Convention Centre (JWCC). This year, InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorpor...

2024-07-27 06:37 1183

Chenghe Acquisition II Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 29, 2024

SINGAPORE, July 27, 2024 /PRNewswire/ -- Chenghe Acquisition II Co. (the " Company") today announced that, commencing on July 29, 2024, holders of the units (the "Units") sold in the Company's initial public offering may elect to separately trade the Company's Class A Ordinary Shares (the "Shares"...

2024-07-27 04:15 1476

Mega Matrix announced that FlexTV App achieved the new milestone, surging into Top 8 on the Apple Store Entertainment Chart (Free Apps, Japan) as of July 26, 2024

PALO ALTO, Calif., July 26, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that FlexTV, its short drama streaming platform, surged into No.8. in the App Store Entertainment Apps (Free Apps,Japan) as of July 26, 2024.
2024-07-27 00:54 1040

vivo Unveils Future Imaging Trends and Announces Winners of VISION+ Mobile PhotoAwards 2024

XINING, China, July 27, 2024 /PRNewswire/ -- vivo today held the 2024 vivo Imaging Conference inXining, China, where it showcased vivo's latest advancements in imaging technologies. The company presented its progressive strategies surrounding three new trends in mobile imaging: imaging security, ...

2024-07-27 00:20 1576

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation

* The positive CHMP opinion is based on results from the Phase II PHAROS trial,[1] which demonstrated an objective response rate (ORR) of 75% in treatment-naïve patients and 46% in previously treated patients. The safety profile is consistent with that observed in the approved metastatic melanoma...

2024-07-26 23:21 1705
Indonesian Philanthropy Association and Tanoto Foundation Launch "Collaboration for the Nation" Book to Drive Transformation in Indonesia's Education Ecosystem

SINGAPORE, July 26, 2024 /PRNewswire/ -- The Indonesian Philanthropy Association (PFI), together with Tanoto Foundation and the Education Philanthropy Cluster, hosted the launch of the book "Collaboration for the Nation: Philanthropy's Contribution to Accelerating Indonesia's Education Agenda" d...

2024-07-26 17:09 1800

Bright Scholar Schedules Unaudited Financial Results for the Third Quarter of Fiscal 2024 Ended May 31, 2024

FOSHAN, China, July 26, 2024 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar," the "Company," "we" or "our") (NYSE: BEDU), a global premier education service company, today announced that it will release its unaudited financial results for the third quarter of fiscal 20...

2024-07-26 17:00 1537

Next Meats and Dr. Foods were both chosen as the finalists of FOODNICHE SUMMIT at Cornell Tech University in New York

TOKYO, July 26, 2024 /PRNewswire/ -- NEXT MEATS Co., Ltd. a Japanese subsidiary ofNEXT MEATS Holdings, Inc. (OTC Market in the US listed corporation as "NXMH") Tokyo based food-tech venture company andDr. Foods Co., Ltd. (A group company of NEXT MEATS Co., Ltd. and, also OTCQB Market in the US li...

2024-07-26 15:48 1535

Dr. Amy Poh Ai Ling's passion to support Malaysian talents who are active on the world stage

TOKYO, July 26, 2024 /PRNewswire/ -- Dr. Amy Poh Ai ling, a researcher at the University of Tokyo, repeatedly says, "I want to give back to my home country, Malaysia." Together with members of the Malaysia-Japan Academic Society, Dr. Amy has enlisted the help of Talent Corporation Malaysia Berhad...

2024-07-26 13:23 1209

Establishing Offshore Development Centers: Comprehensive Insights from Saigon Technology

HO CHI MINH CITY, Vietnam, July 26, 2024 /PRNewswire/ -- In the dynamic landscape of the global economy, businesses are continually seeking strategies to optimize operations, reduce costs, and accelerate time-to-market. Offshore Development Centers (ODCs)
2024-07-26 06:00 1409
InfoComm India 2024 -The Largest Edition of the Pro AV Exhibition to Date - Returns 3-5 September at Jio World Convention Centre (JWCC) Mumbai, India

MUMBAI, India, July 26, 2024 /PRNewswire/ -- InfoComm India, India's foremost professional audiovisual (Pro AV) exhibition, is set to return toMumbai from 3-5 September 2024 at the Jio World Convention Centre (JWCC). This year, InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorpor...

2024-07-27 06:37 1183

Mega Matrix announced that FlexTV App achieved the new milestone, surging into Top 8 on the Apple Store Entertainment Chart (Free Apps, Japan) as of July 26, 2024

PALO ALTO, Calif., July 26, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that FlexTV, its short drama streaming platform, surged into No.8. in the App Store Entertainment Apps (Free Apps,Japan) as of July 26, 2024.
2024-07-27 00:54 1040

vivo Unveils Future Imaging Trends and Announces Winners of VISION+ Mobile PhotoAwards 2024

XINING, China, July 27, 2024 /PRNewswire/ -- vivo today held the 2024 vivo Imaging Conference inXining, China, where it showcased vivo's latest advancements in imaging technologies. The company presented its progressive strategies surrounding three new trends in mobile imaging: imaging security, ...

2024-07-27 00:20 1576

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation

* The positive CHMP opinion is based on results from the Phase II PHAROS trial,[1] which demonstrated an objective response rate (ORR) of 75% in treatment-naïve patients and 46% in previously treated patients. The safety profile is consistent with that observed in the approved metastatic melanoma...

2024-07-26 23:21 1705

WiMi Built an Advanced Data Structure Architecture Using Homomorphic Encryption and Federated Learning

BEIJING, July 26, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it utilized homomorphic encryption and federated learning building an advanced data structure arch...

2024-07-26 21:00 1797
Chenghe Acquisition II Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 29, 2024

SINGAPORE, July 27, 2024 /PRNewswire/ -- Chenghe Acquisition II Co. (the " Company") today announced that, commencing on July 29, 2024, holders of the units (the "Units") sold in the Company's initial public offering may elect to separately trade the Company's Class A Ordinary Shares (the "Shares"...

2024-07-27 04:15 1476

CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer

* Sugemalimab becomes the world's first anti-PD-L1 monoclonal antibody (mAb) approved inEurope for first-line treatment of both squamous and non-squamous non-small cell lung cancer (NSCLC), also marking the first successful international approval of aChina domestic anti-PD-L1 mAb. * The Europea...

2024-07-26 20:16 2133

Nature's Miracle Holding Inc. Announces Pricing of $1.2 Million Public Offering

ONTARIO, Calif., July 26, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today announced the pricing of a public offering of 5,000,000 units (the "Units") consisting of (i) one sh...

2024-07-26 20:00 1083

2024 CICC GBA Wealth Management Forum successfully held in Hong Kong

BEIJING, July 26, 2024 /PRNewswire/ -- On 25th July, China International Capital Corporation Limited (CICC) successfully held the 2024 CICC GBA Wealth Management Forum inHong Kong. Themed "Developing New Quality Productive Forces, Driving New Momentum in Wealth", the forum gathered a multitude of...

2024-07-26 18:52 1011

BRI Prudent Strategy Yields IDR29.90 Trillion Profit in Q2 2024

JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ -- Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) and its subsidiaries, BRI Group, reported a profit of IDR 29.90 trillion in the Second Quarter of 2024, achieved through selective and prudent growth. This was announced byBRI President Director, Sun...

2024-07-26 18:30 2010
Warner Bros. World™ Yas Island, Abu Dhabi soars to new heights with Etihad Airways partnership

ABU DHABI, UAE, July 26, 2024 /PRNewswire/ -- Warner Bros. World™ Yas Island, Abu Dhabi, the region's largest indoor theme park, is thrilled to announce a groundbreaking extension to its partnership with Etihad Airways, marking a monumental milestone in its history. This exciting collaboration wa...

2024-07-26 23:17 1529

MHX Jakarta 18-21 July 2024 Wrapped Up with Record Turnout, High Leads Generation and Strategic Partnerships

JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) achieved impressive results in numerous fronts inJakarta! MHTC is the pioneer in organising healthcare expo inIndonesia and the inaugural event was in Semarang in 2012. MHTC has successfully organised two ...

2024-07-26 21:02 1928

Xinhua Silk Road: NE. China's Harbin becomes popular summer tourism destination with rich wetland resources

BEIJING, July 26, 2024 /PRNewswire/ -- Boasting rich wetland resources, Harbin City in northeastChina's Heilongjiang Province has become a popular tourism destination in summer days this year. Photo shows the Hulan River estuary wetland park in...

2024-07-26 20:19 1963

Grand exhibition of ancient Egyptian artifacts to open at Shanghai Museum

SHANGHAI, July 26, 2024 /PRNewswire/ -- A news report from english.shanghai.gov.cn: Photos by Gao Erqiang/chinadaily.com.cn The exhibition On Top of the Pyramid: The Civilization of Ancient Egypt opened to the publ...

2024-07-26 15:59 1092

UnionPay International Enhances European Airport Acceptance, Upgrades Payment Services for Summer Travelers

Improved UnionPay Card Acceptance at Major European Airports PARIS, July 26, 2024 /PRNewswire/ -- As the summer travel season heats up, more tourists are flocking toEurope, and UnionPay card acceptance at point-of-sale (POS) terminals inEurope now exceeds 80%. UnionPay International is making st...

2024-07-26 13:43 1313
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation

* The positive CHMP opinion is based on results from the Phase II PHAROS trial,[1] which demonstrated an objective response rate (ORR) of 75% in treatment-naïve patients and 46% in previously treated patients. The safety profile is consistent with that observed in the approved metastatic melanoma...

2024-07-26 23:21 1705

MHX Jakarta 18-21 July 2024 Wrapped Up with Record Turnout, High Leads Generation and Strategic Partnerships

JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) achieved impressive results in numerous fronts inJakarta! MHTC is the pioneer in organising healthcare expo inIndonesia and the inaugural event was in Semarang in 2012. MHTC has successfully organised two ...

2024-07-26 21:02 1928

ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders

BRISBANE, Calif., July 26, 2024 /PRNewswire/ -- ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today that it has successfully completed a$30 million Series A financing, bringing the total raised so f...

2024-07-26 21:00 1200

CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer

* Sugemalimab becomes the world's first anti-PD-L1 monoclonal antibody (mAb) approved inEurope for first-line treatment of both squamous and non-squamous non-small cell lung cancer (NSCLC), also marking the first successful international approval of aChina domestic anti-PD-L1 mAb. * The Europea...

2024-07-26 20:16 2133

MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports

PARIS, July 26, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced its collaboration with renowned geneticist, Professor Yannis Pitsiladis from Hong Kong Baptist University, on sports a...

2024-07-26 19:35 1158